Lexicon Pharmaceuticals (LXRX) Cost of Revenue (2017 - 2026)
Lexicon Pharmaceuticals (LXRX) recorded Cost of Revenue of $39,000 in Q2 2026, up 18.2% from $33,000 a year earlier but down 63.9% from the prior quarter.
Powered by 
Analysis
Lexicon Pharmaceuticals (LXRX) Cost of Revenue (2017 - 2026) Analysis & Trends
On a TTM basis, Lexicon Pharmaceuticals' Cost of Revenue came in at $358,000 as of Jun 30, 2026, down 25.7% year-over-year; for FY2025, it was $274,000, down 55.5% from FY2024.
- Annual Cost of Revenue has a five-year compound annual growth rate of -32.3% (FY2020 to FY2025).
- Across earlier years, Cost of Revenue came in at $616,000 in FY2024 (+624.7%) and $85,000 in FY2023.
- Quarterly Cost of Revenue has ranged from $7,000 in Q3 2023 to $348,000 in Q4 2024 over the past five years.
- On a year-over-year basis, Cost of Revenue rose in four of the last eight quarters, with growth averaging 172.3%.
- Peak year-over-year performance for Cost of Revenue in the last five years was growth of 914.3% in Q3 2024, against a decline of 85.9% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $108,000 (Q1 2026), $201,000 (Q4 2025) and $10,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Lexicon Pharmaceuticals | 813.30 Mn | 239.86 Mn | 653,000.00 | 39,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39,000.00 |
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 201,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Dec 31, 2024 | 348,000.00 |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 166,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Sep 30, 2020 | 633,000.00 |
| Jun 30, 2020 | 728,000.00 |
| Mar 31, 2020 | 568,000.00 |
| Dec 31, 2019 | 774,000.00 |
| Sep 30, 2019 | 577,000.00 |
| Jun 30, 2019 | 1.33 Mn |
| Mar 31, 2019 | 553,000.00 |
API Access
Lexicon Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=LXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "LXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=LXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();